tumor vaccination
Recently Published Documents


TOTAL DOCUMENTS

133
(FIVE YEARS 18)

H-INDEX

21
(FIVE YEARS 1)

Author(s):  
Yuang Chen ◽  
Yixian Huang ◽  
Haozhe Huang ◽  
Zhangyi Luo ◽  
Ziqian Zhang ◽  
...  
Keyword(s):  

2021 ◽  
Vol 33 (31) ◽  
pp. 2170244
Author(s):  
Worapol Ngamcherdtrakul ◽  
Moataz Reda ◽  
Molly A. Nelson ◽  
Ruijie Wang ◽  
Husam Y. Zaidan ◽  
...  

2021 ◽  
pp. 2100628
Author(s):  
Worapol Ngamcherdtrakul ◽  
Moataz Reda ◽  
Molly A. Nelson ◽  
Ruijie Wang ◽  
Husam Y. Zaidan ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 409
Author(s):  
Enrique Gómez Alcaide ◽  
Sinduya Krishnarajah ◽  
Fabian Junker

Despite significant recent improvements in the field of immunotherapy, cancer remains a heavy burden on patients and healthcare systems. In recent years, immunotherapies have led to remarkable strides in treating certain cancers. However, despite the success of checkpoint inhibitors and the advent of cellular therapies, novel strategies need to be explored to (1) improve treatment in patients where these approaches fail and (2) make such treatments widely and financially accessible. Vaccines based on tumor antigens (Ag) have emerged as an innovative strategy with the potential to address these areas. Here, we review the fundamental aspects relevant for the development of cancer vaccines and the critical role of dendritic cells (DCs) in this process. We first offer a general overview of DC biology and routes of Ag presentation eliciting effective T cell-mediated immune responses. We then present new therapeutic avenues specifically targeting Fc gamma receptors (FcγR) as a means to deliver antigen selectively to DCs and its effects on T-cell activation. We present an overview of the mechanistic aspects of FcγR-mediated DC targeting, as well as potential tumor vaccination strategies based on preclinical and translational studies. In particular, we highlight recent developments in the field of recombinant immune complex-like large molecules and their potential for DC-mediated tumor vaccination in the clinic. These findings go beyond cancer research and may be of relevance for other disease areas that could benefit from FcγR-targeted antigen delivery, such as autoimmunity and infectious diseases.


Nano Letters ◽  
2021 ◽  
Vol 21 (3) ◽  
pp. 1228-1237
Author(s):  
Zhouqi Meng ◽  
Yaojia Zhang ◽  
Jialin She ◽  
Xuanfang Zhou ◽  
Jun Xu ◽  
...  

2021 ◽  
Author(s):  
Xinran Song ◽  
Huoyan Hong ◽  
Gomaa El Fawal ◽  
Jinglei Wu ◽  
Di Jiang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document